Kidney cancer trials in Taiwan

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 1/2Taking people
  Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

  Where

  Changhua, Kaohsiung City, Tainan, Taipei

  Age

  18 years and over

  People

  340 worldwide

  Run by

  Inhibrx Biosciences, Inc

  See details and how to joinNCT04198766
• Phase 3Taking people
  A Clinical Study of Belzutifan and Zanzalintinib in People With Recurrent Kidney Cancer Following Adjuvant Therapy (MK-6482-033)

  Where

  Taichung, Taipei, Taoyuan

  Age

  18 years and over

  People

  904 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT07227402 · EU 2024-517136-21-00
• Phase 2Taking people
  APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

  Where

  Taipei

  Age

  18 years and over

  People

  497 worldwide

  Run by

  Apollomics Inc.

  See details and how to joinNCT03175224 · EU 2024-514542-37-00
• Phase 1Taking people
  A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.

  Where

  Taichung, Tainan

  Age

  18 years and over

  People

  24

  Run by

  LaunXP Biomedical Co., Ltd.

  See details and how to joinNCT06883539
• No phaseTaking people
  Urine Omics Predicting IO Therapy Responses in mRCC Patients

  Where

  Taipei

  Age

  20 years and over

  People

  400

  Run by

  National Taiwan University Hospital

  See details and how to joinNCT04712305